Navigation Links
eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Date:2/26/2008

red to net income of $8.3 million, or $0.16 per diluted share, for 2006, an 83.5% increase. The Company's effective tax rate was 37.6% for 2007 compared to 37.1% for 2006.

Cash flow from operations for 2007 was $36.0 million, up from $16.3 million in 2006. After completing the CCSS transaction of $35.8 million, eRT ended the year with $46.9 million in cash, cash equivalents and investments.

Commenting on the year as a whole, Dr. McKelvey said "Our success in 2007 gives us a strong basis for growth in 2008 and beyond. We enter 2008 with a healthy backlog, a good trajectory of revenue growth, enhanced scale and increased market share from our recent acquisition, a strong pipeline of bookings opportunities and a state-of-the-art new workflow system (EXPeRT(R) 2) that provides us with a scalable platform for operational excellence. The clinical trials industry continues to focus on the importance of cardiac safety and running Thorough QTc trials. In addition, we also invested in our eClinical line of business and launched a new line of business -- electronic patient reported outcomes (ePRO)." As for 2008, Dr. Michael McKelvey concluded: "The strong momentum that we developed throughout 2007, along with a healthy overall business environment for cardiac safety and the need for technology-based solutions for clinical trials, gives us confidence that we will have a successful 2008."

2008 Guidance

The Company issued guidance for the first quarter of 2008. eRT anticipates net revenues of between $31.0 million and $33.0 million and net income per diluted share of $0.08 to $0.10 for the first quarter ending March 31, 2008. For the full year ending December 31, 2008, management anticipates net revenues of between $130 million and $137 million. Management anticipates earnings per diluted share of between $0.42 and $0.46 for the full year ending December 31, 2008. This guidance includes the costs associated with the closing of the Reno facility and oth
'/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
2. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
3. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 Kitware , ... announces a new Fast-Track award from the U.S. Department ... environment (IDAE) for the nuclear power industry. , Construction ... more than 30 years, but the United States’ nuclear ... gains in power plant utilization through improved refueling, maintenance, ...
(Date:6/17/2013)... Belvoir, VA (PRWEB) June 17, 2013 ... annual Basic Research Technical Review at the Waterford in ... More than 300 grant awardees will present technical details ... Technical sessions will cover a broad range of counter ... (2) Cognitive, Information and Network Science; (3) Science for ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 With the huge ... launch of the Chief Medical Officer Summit for Emerging Life ... will take place in San Francisco on November 4-5, 2013 ... the first time, West Coast Chief Medical Officers at biotechs ... Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive ...
(Date:6/17/2013)... June 17, 2013 ... announced the addition of the "North ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics- Forecasts ... ,      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
Breaking Biology Technology:Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3
... having the next big thing is not enough. , ... mid-sized firm occupying several hard-won niches, or a high-energy ... says Tom Miller, an intellectual property lawyer with Michael ... presentation to eInnovate, a Milwaukee-based technology forum, Miller said ...
... Giannantonio, CIO at Lands' End, takes pride in his organization's ... you can't separate the business folks from the IT folks," ... and down the organization, from Frank sitting on the executive ... to the way IT supports picking and packing of orders ...
... Wisconsin is one of six states to receive a ... law enforcement network further into the Internet age. , ... state's Office of Justice Assistance, which houses the ... charged with maintaining, promoting and coordinating automated justice information ...
Cached Biology Technology:Protect your intellectual property before it's too late 2Protect your intellectual property before it's too late 3Frank Giannantonio blends IT and business for Lands' End 2Frank Giannantonio blends IT and business for Lands' End 3Frank Giannantonio blends IT and business for Lands' End 4State receives grant for justice information sharing 2
(Date:6/15/2013)... in Europe to treat osteoporosis has now been shown ... in cancers that have become resistant to current targeted ... The findings, presented June 15, 2013, at the annual ... drug bazedoxifene packs a powerful one-two punch that not ... but also flags the estrogen receptor for destruction. , ...
(Date:6/14/2013)... Oklahoma researchers will collaborate with researchers from Oklahoma ... the University of Tulsa to advance understanding of ... climate change and variability in the state. , ... receive a $20 million National Science Foundation Experimental ... strategically aligned, innovative research over the next five ...
(Date:6/14/2013)... the only ones tending their gardens. , At the ... ants cultivate thriving communities of fungi and bacteria using ... are a source of food and shelter for the ... biofuel production. , "We are interested in the whole ... goes in and is converted to energy for the ...
Breaking Biology News(10 mins):Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3Researchers unearth bioenergy potential in leaf-cutter ant communities 2Researchers unearth bioenergy potential in leaf-cutter ant communities 3
... the humble mustard plant, scientists at the University of ... while investigating how plants respond to attacks from disease ... what we thought we'd find, our experiments showed that ... one another in tug-of war or teeter totter-fashion to ...
... pink, bacterial scum on the floor of an abandoned mine ... biological breakthrough is allowing University of California, Berkeley, researchers to ... Last year, the UC Berkeley team joined with the Department ... of the five dominant bacteria in a slime, or biofilm, ...
... have discovered that a single protein regulates secretion levels ... outer layer. , Described in the May 15 issue ... become specialized for secretion, which is a critical ability ... insects to humans. , The researchers discovered that a ...
Cached Biology News:FDA approves more generic AIDS drugs 2FDA approves more generic AIDS drugs 3Proteomics brings researchers closer to understanding microbes that produce acid mine drainage 2Proteomics brings researchers closer to understanding microbes that produce acid mine drainage 3Proteomics brings researchers closer to understanding microbes that produce acid mine drainage 4Proteomics brings researchers closer to understanding microbes that produce acid mine drainage 5Study: Well-known protein helps stem cells become secretory cells 2
... 50mM Tris-HCl, pH 7.5, 0.1mM ... 1mM benzamidine, 0.1% 2-mercaptoethanol and ... Phosphatase 2A1) partially purified enzyme ... QSepharose,amino-hexyl agarose, Superdex 200, and ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
...
... Anti-HMGN2/HMG-17 Immunogen : Recombinant ... pH7.4, 5mg/ml BSA, 0.15M NaCl, ... addition of glycerol to 30% ... immunoblot on acid extracts of ...
Biology Products: